Cargando…

Epstein–Barr virus-associated gastric cancer reveals intratumoral heterogeneity of PIK3CA mutations

BACKGROUND: Recent whole-genome sequencing identified four molecular subtypes of gastric cancer (GC), of which the subgroup of Epstein–Barr virus-associated GC (EBVaGC) showed a significant enrichment of PIK3CA mutations. We here aimed to validate independently the enrichment of PIK3CA mutations in...

Descripción completa

Detalles Bibliográficos
Autores principales: Böger, C., Krüger, S., Behrens, H. M., Bock, S., Haag, J., Kalthoff, H., Röcken, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406766/
https://www.ncbi.nlm.nih.gov/pubmed/28453696
http://dx.doi.org/10.1093/annonc/mdx047
_version_ 1783232024644943872
author Böger, C.
Krüger, S.
Behrens, H. M.
Bock, S.
Haag, J.
Kalthoff, H.
Röcken, C.
author_facet Böger, C.
Krüger, S.
Behrens, H. M.
Bock, S.
Haag, J.
Kalthoff, H.
Röcken, C.
author_sort Böger, C.
collection PubMed
description BACKGROUND: Recent whole-genome sequencing identified four molecular subtypes of gastric cancer (GC), of which the subgroup of Epstein–Barr virus-associated GC (EBVaGC) showed a significant enrichment of PIK3CA mutations. We here aimed to validate independently the enrichment of PIK3CA mutations in EBVaGC of a Central European GC cohort, to correlate EBV status with clinico-pathological patient characteristics and to test for a major issue of GC, intratumoral heterogeneity. PATIENTS AND METHODS: In a first step, 484 GCs were screened for EBV and PIK3CA hot spot mutations of exon 9/20 using EBER in situ hybridization and pyrosequencing, respectively. Secondly, an extended sequencing of PIK3CA also utilizing next generation sequencing was carried out in all EBVaGCs and 96 corresponding lymph node metastases. RESULTS: Twenty-two GCs were EBER-positive, all being of latency type I. Intratumoral heterogeneity of EBER-positivity was found in 18% of EBVaGCs. Twenty-three GCs held PIK3CA mutations in hot spot regions of exon 9 or 20, being significantly more common in EBVaGCs (P < 0.001). Subsequent extended sequencing of PIK3CA of EBVaGCs showed that 14% harvested three to five different PIK3CA genotypes (including wildtype) in the same primary tumor, albeit in histologically and spatially distinct tumor areas, and that intratumoral heterogeneity of PIK3CA was also present in the corresponding lymph node metastases. CONCLUSIONS: Our findings unravel issues of tumor heterogeneity and illustrate that the assessment of the EBV status in tissue biopsies might carry the risk of sampling errors, which may significantly hamper adequate molecular tumor classification in a more clinical setting. Moreover, this is the first report of intratumoral heterogeneity of PIK3CA mutations in GC, and our findings lead to the conclusion that PIK3CA mutant and -wildtype tumor subclones are skilled to metastasize independently to different regional lymph nodes.
format Online
Article
Text
id pubmed-5406766
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-54067662018-03-12 Epstein–Barr virus-associated gastric cancer reveals intratumoral heterogeneity of PIK3CA mutations Böger, C. Krüger, S. Behrens, H. M. Bock, S. Haag, J. Kalthoff, H. Röcken, C. Ann Oncol Original Articles BACKGROUND: Recent whole-genome sequencing identified four molecular subtypes of gastric cancer (GC), of which the subgroup of Epstein–Barr virus-associated GC (EBVaGC) showed a significant enrichment of PIK3CA mutations. We here aimed to validate independently the enrichment of PIK3CA mutations in EBVaGC of a Central European GC cohort, to correlate EBV status with clinico-pathological patient characteristics and to test for a major issue of GC, intratumoral heterogeneity. PATIENTS AND METHODS: In a first step, 484 GCs were screened for EBV and PIK3CA hot spot mutations of exon 9/20 using EBER in situ hybridization and pyrosequencing, respectively. Secondly, an extended sequencing of PIK3CA also utilizing next generation sequencing was carried out in all EBVaGCs and 96 corresponding lymph node metastases. RESULTS: Twenty-two GCs were EBER-positive, all being of latency type I. Intratumoral heterogeneity of EBER-positivity was found in 18% of EBVaGCs. Twenty-three GCs held PIK3CA mutations in hot spot regions of exon 9 or 20, being significantly more common in EBVaGCs (P < 0.001). Subsequent extended sequencing of PIK3CA of EBVaGCs showed that 14% harvested three to five different PIK3CA genotypes (including wildtype) in the same primary tumor, albeit in histologically and spatially distinct tumor areas, and that intratumoral heterogeneity of PIK3CA was also present in the corresponding lymph node metastases. CONCLUSIONS: Our findings unravel issues of tumor heterogeneity and illustrate that the assessment of the EBV status in tissue biopsies might carry the risk of sampling errors, which may significantly hamper adequate molecular tumor classification in a more clinical setting. Moreover, this is the first report of intratumoral heterogeneity of PIK3CA mutations in GC, and our findings lead to the conclusion that PIK3CA mutant and -wildtype tumor subclones are skilled to metastasize independently to different regional lymph nodes. Oxford University Press 2017-05 2017-02-09 /pmc/articles/PMC5406766/ /pubmed/28453696 http://dx.doi.org/10.1093/annonc/mdx047 Text en © The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Original Articles
Böger, C.
Krüger, S.
Behrens, H. M.
Bock, S.
Haag, J.
Kalthoff, H.
Röcken, C.
Epstein–Barr virus-associated gastric cancer reveals intratumoral heterogeneity of PIK3CA mutations
title Epstein–Barr virus-associated gastric cancer reveals intratumoral heterogeneity of PIK3CA mutations
title_full Epstein–Barr virus-associated gastric cancer reveals intratumoral heterogeneity of PIK3CA mutations
title_fullStr Epstein–Barr virus-associated gastric cancer reveals intratumoral heterogeneity of PIK3CA mutations
title_full_unstemmed Epstein–Barr virus-associated gastric cancer reveals intratumoral heterogeneity of PIK3CA mutations
title_short Epstein–Barr virus-associated gastric cancer reveals intratumoral heterogeneity of PIK3CA mutations
title_sort epstein–barr virus-associated gastric cancer reveals intratumoral heterogeneity of pik3ca mutations
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406766/
https://www.ncbi.nlm.nih.gov/pubmed/28453696
http://dx.doi.org/10.1093/annonc/mdx047
work_keys_str_mv AT bogerc epsteinbarrvirusassociatedgastriccancerrevealsintratumoralheterogeneityofpik3camutations
AT krugers epsteinbarrvirusassociatedgastriccancerrevealsintratumoralheterogeneityofpik3camutations
AT behrenshm epsteinbarrvirusassociatedgastriccancerrevealsintratumoralheterogeneityofpik3camutations
AT bocks epsteinbarrvirusassociatedgastriccancerrevealsintratumoralheterogeneityofpik3camutations
AT haagj epsteinbarrvirusassociatedgastriccancerrevealsintratumoralheterogeneityofpik3camutations
AT kalthoffh epsteinbarrvirusassociatedgastriccancerrevealsintratumoralheterogeneityofpik3camutations
AT rockenc epsteinbarrvirusassociatedgastriccancerrevealsintratumoralheterogeneityofpik3camutations